Novo Nordisk, the Danish pharmaceutical giant, has entered a significant partnership with Vivtex, a biotech startup co-founded by renowned entrepreneur Robert Langer, to develop innovative oral formulations of its obesity
Novo Nordisk, the Danish pharmaceutical giant, has entered a significant partnership with Vivtex, a biotech startup co-founded by renowned entrepreneur Robert Langer, to develop innovative oral formulations of its obesity
Novo Holdings, the controlling shareholder of Novo Nordisk, reported a remarkable annual performance despite facing a challenging global economic landscape. The investment company, which manages the assets of the Novo






